ヒドロキシエチルルトシド
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/06/17 02:08:06」(JST)
[Wiki en表示]
Hydroxyethylrutosides (oxerutins, O-beta-hydroxyethyl-rutosides, HR or HER) are hydroxyethyl acetylations of rutoside. It may refer to :
- Monoxerutin
- Dihydroxyethylrutoside
- Troxerutin
- Tetrahydroxyethylrutoside
Oxerutins are semisynthetic derivatives of plant constituents. Although they are closely related to the natural flavonoid rutin, hydroxyethylrutosides are not found in food. The only way to take them is in a supplement.[1]
Health benefits
Relvène (1967 French version), Venoruton (1962 Swiss version), and Paroven are mixtures of hydroxyethyl rutinosides. Hydroxyethylrutosides are used in the treatment of chronic venous insufficiency[2] and hypertensive microangiopathy.[3] Oxerutins works by reducing leakage from the small blood vessels (capillaries).[4]
Hydroxyethylrutosides have been used as an alternative to horse chestnut preparations (venostasin) containing aescin. Typical doses are in the order of 1,000 mg/day.[5]
Effects of hydroxyethylrutosides against adriamycin-induced toxicity have been investigated in rats.[6]
References
- ^ Oxerutins on healthlibrary.epnet.com
- ^ Frick, RW (2000). "Three treatments for chronic venous insufficiency: Escin, hydroxyethylrutoside, and Daflon". Angiology 51 (3): 197–205. doi:10.1177/000331970005100303. PMID 10744007.
- ^ Incandela, L; Belcaro, G; Renton, S; Desanctis, MT; Cesarone, MR; Bavera, P; Ippolito, E; Bucci, M et al. (2002). "HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: A prospective, placebo-controlled, randomized trial". Journal of cardiovascular pharmacology and therapeutics. 7 Suppl 1: S7–S10. doi:10.1177/107424840200700103. PMID 12011966.
- ^ Paroven on netdoctor.co.uk
- ^ The handbook of clinically tested herbal remedies, Volume 2 by Marilyn Barrett
- ^ Gulati, OP; Nordmann, H; Aellig, A; Maignan, MF; McGinness, J (1985). "Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats". Archives internationales de pharmacodynamie et de therapie 273 (2): 323–34. PMID 4004421.
Vasoprotectives (C05)
|
|
Antihemorrhoidals for topical use |
corticosteroids |
- Hydrocortisone
- Prednisolone
- Betamethasone
- Fluorometholone
- Fluocortolone
- Dexamethasone
- Fluocinolone acetonide
- Fluocinonide
|
|
local anesthetics |
- Lidocaine
- Tetracaine
- Benzocaine
- Dibucaine
- Procaine
- Oxetacaine
- Pramocaine
|
|
other |
|
|
|
Antivaricose therapy |
heparins or heparinoids for topical use |
- Organo-heparinoid
- Sodium apolate
- Heparin
- Pentosan polysulfate
|
|
sclerosing agents for local injection |
- Monoethanolamine oleate
- Polidocanol
- Inverted sugar syrup
- Sodium tetradecyl sulfate
- Phenol
|
|
other |
|
|
|
Capillary stabilising agents |
bioflavonoids |
- Rutoside
- Monoxerutin
- Diosmin
- Troxerutin
- Hidrosmin
|
|
other |
|
|
|
|
anat (a:h/u/t/a/l,v:h/u/t/a/l)/phys/devp/cell/prot
|
noco/syva/cong/lyvd/tumr, sysi/epon, injr
|
proc, drug (C2s+n/3/4/5/7/8/9)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Troxerutin inhibits 2,2',4,4'-tetrabromodiphenyl ether (BDE-47)-induced hepatocyte apoptosis by restoring proteasome function.
- Zhang ZF1, Shan Q1, Zhuang J2, Zhang YQ3, Wang X4, Fan SH5, Lu J5, Wu DM5, Hu B5, Zheng YL6.
- Toxicology letters.Toxicol Lett.2015 Mar 18;233(3):246-57. doi: 10.1016/j.toxlet.2015.01.017. Epub 2015 Jan 29.
- Proteasome dysfunction has been associated with the pathogeneses of a variety of diseases and with the neurotoxicities of environmental chemicals; however, whether proteasome dysfunction plays a role in the cellular toxicity of polybrominated diphenyl ethers (PBDEs) has not been investigated to date
- PMID 25639565
- The flavonoid monoHER promotes the adaption to oxidative stress during the onset of NAFLD.
- Lemmens KJ1, van de Wier B2, Koek GH3, Köhler E4, Drittij MJ2, van der Vijgh WJ2, Bast A2, Haenen GR5.
- Biochemical and biophysical research communications.Biochem Biophys Res Commun.2015 Jan 2;456(1):179-82. doi: 10.1016/j.bbrc.2014.11.055. Epub 2014 Nov 22.
- Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease. An evidence-based pharmacological treatment for NAFLD is still lacking, but flavonoids have shown therapeutic potential. The present study was designed to investigate the effect of the flavonoid monoHER on the onset of NAFLD
- PMID 25462563
- [Prophylaxis of thrombohemorrhagic complications in surgical treatment of chemoresistant pulmonary tuberculosis].
- Duzhyĭ ID, Kravets' OV, Hres'ko IIa, Iurchenko AV.
- Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukraïny, Naukove tovarystvo khirurhiv Ukraïny.Klin Khir.2014 Oct;(10):44-7.
- Analysis of thrombohemorrhagic complications was conducted in 98 patients, operated on for various forms of chemoresistant pulmonary tuberculosis. To prevent such complications it is necessary to prescribe heparin in minimal doses or fraxiparine preoperatively and intraoperatively. It permits to low
- PMID 25675787
Related Links
- Hydroxyethylrutoside information including symptoms, causes, diseases, symptoms, treatments, and other medical and health issues. ... Introduction: Hydroxyethylrutoside Description of Hydroxyethylrutoside Hydroxyethylrutoside: Monohydroxyethyl derivative of rutin.
- Definition of hydroxyethylrutoside in the Definitions.net dictionary. Meaning of hydroxyethylrutoside. What does hydroxyethylrutoside mean? Information and translations of hydroxyethylrutoside in the most comprehensive dictionary ...
Related Pictures